Showing results (11-20 of 969) with videos related to

Sort By:
Pageof 97
Advances in Experimental Medicine and Biology|March 22, 2017
Harnessing the Immune System Against Leukemia: Monoclonal Antibodies and Checkpoint Strategies for AMLLucia Masarova, Hagop Kantarjian, Guillermo Garcia-Mannero, et al.
Advances in Experimental Medicine and Biology|December 13, 2018
Update on Immunotherapy in AML and MDS: Monoclonal Antibodies and Checkpoint Inhibitors Paving the Road for Clinical PracticeLucia Masarova, Hagop Kantarjian, Farhad Ravandi, et al.
Blood|March 22, 2015
Secondary mutations as mediators of resistance to targeted therapy in leukemiaNaval Daver, Jorge Cortes, Farhad Ravandi, et al.
Cancer Discovery|February 5, 2020
Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New ChallengesNicholas J Short, Marina Konopleva, Tapan M Kadia, et al.
Frontiers in Oncology|January 27, 2022
CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid LeukemiaOren Pasvolsky, May Daher, Gheath Alatrash, et al.
Best Practice & Research. Clinical Haematology|March 25, 2021
Immune checkpoint inhibitors in acute myeloid leukemiaNaval Daver
Blood Cancer Discovery|November 20, 2024
Venetoclax-Based Combination Regimens in Acute Myeloid LeukemiaHannah Goulart, Hagop Kantarjian, Naveen Pemmaraju, et al.
Blood Cancer Journal|February 23, 2021
Acute myeloid leukemia: current progress and future directionsHagop Kantarjian, Tapan Kadia, Courtney DiNardo, et al.
Haematologica|April 26, 2012
Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemiaAziz Nazha, Jorge Cortes, Stefan Faderl, et al.
Critical Reviews in Oncology/Hematology|January 23, 2017
Frontline treatment of acute myeloid leukemia in adultsGevorg Tamamyan, Tapan Kadia, Farhad Ravandi, et al.
Pageof 97